Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Country Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Blood Collection Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Chronic and Infectious Diseases
3.2.1.2. Growing Number of Blood Transfusions
3.2.1.3. Rising Prevalence of Hematological Disorders
3.2.2. Market Restraint Analysis
3.2.2.1. Risks Associated with Blood Collection
3.2.2.2. Stringent Regulations on Blood Collection
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Blood Collection Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Estimated Animal Population, by key countries & Key species, 2024
3.3.6. COVID-19 Impact Analysis
Chapter 4. U.S. Blood Collection Market: Site Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Blood Collection Market: Site Movement Analysis
4.3. U.S. Blood Collection Market Size & Trend Analysis, by Site, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
4.4. Venous
4.4.1. Venous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
4.4.1.1. Needles and Syringes
4.4.1.1.1. Double-Ended Needles
4.4.1.1.2. Winged Blood Collection Sets
4.4.1.1.3. Standard Hypodermic Needles
4.4.1.1.4. Other Blood Collection Needles
4.4.1.2. Blood Collection Tubes
4.4.1.2.1. Serum-separating tubes
4.4.1.2.2. EDTA
4.4.1.2.3. Heparin
4.4.1.2.4. Plasma-separating
4.4.1.3. Blood Bags
4.4.1.4. Others
4.5. Capillary
4.5.1. Capillary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
4.5.2. Lancets
4.5.3. Micro-Container Tubes
4.5.4. Micro-Hematocrit Tubes
4.5.5. Warming Devices
4.5.6. Others
Chapter 5. U.S. Blood Collection Market: By Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Blood Collection Market: By Application Movement Analysis
5.3. U.S. Blood Collection Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
5.4. Diagnostics
5.4.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
5.5. Treatment
5.5.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
Chapter 6. U.S. Blood Collection Market: By End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Blood Collection Market: By End Use Movement Analysis
6.3. U.S. Blood Collection Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
6.4. Hospitals
6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.5. Clinical Laboratories
6.5.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.6. Blood Banks Centers
6.6.1. Blood Banks Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.7. Clinics
6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.8. Mobile Service
6.8.1. Mobile Service Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.9. Emergency Departments
6.9.1. Emergency Departments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
6.10. , Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
Chapter 7. U.S. Blood Collection Market: By Age Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Blood Collection Market: By Age Movement Analysis
7.3. U.S. Blood Collection Market Size & Trend Analysis, by Age, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
7.3.1. 0-18
7.3.1.1. 0-18 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
7.3.2. 19 to 65
7.3.2.1. 19 to 65 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
7.3.3. 66 years and above
7.3.3.1. 66 years and Above Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
Chapter 8. U.S. Blood Collection Market: By Demography Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Blood Collection Market: By Demographic Movement Analysis
8.3. U.S. Blood Collection Market Size & Trend Analysis, by Demographic, 2018 to 2030 (USD Million) (Volume, Units Sold in Million)
8.3.1. Urban
8.3.1.1. Urban Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
8.3.2. Rural
8.3.2.1. Rural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Units Sold in Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Sekisui Medical Co., Ltd.
9.3.1.1. Company overview
9.3.1.2. Financial performance
9.3.1.3. Product benchmarking
9.3.1.4. Strategic initiatives
9.3.2. Becton, Dickinson and Company (BD)
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Greiner Bio-One
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. QIAGEN
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Nipro Corporation
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Terumo Corporation
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Haemonetics Corp.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Zhejiang Gongdong Medical Technology Co., Ltd
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Drucker Diagnostics
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. AdvaCare Pharma
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Expansion
9.4.4. Product launch
9.4.5. Others
9.5. List of other Key players
List of Tables
Table 1 List of secondary sources
Table 2 Percentage of adults aged =18 years with diagnosed heart disease, by age group and urbanization level in the U.S., in 2020
Table 3 Healthcare expenditures attributable to diabetes in the U.S., by demographic, in 2024
Table 4 Total blood donations by age in the U.S.
Table 5 Estimated new leukemia cancer cases and deaths by U.S. State, in 2024
Table 6 Blood collection fatalities in the U.S., October 2020-September 2021
Table 7 Percentage of population aged 65 or older in the U.S., in 2020
Table 8 U.S. blood collection market revenue estimates and forecast, by site, 2018 - 2030 (USD Million)
Table 9 U.S. blood collection market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
Table 10 U.S. blood collection market revenue estimates and forecast, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. blood collection market revenue estimates and forecast, by Age, 2018 - 2030 (USD Million)
Table 12 U.S. blood collection market revenue estimates and forecast, by Demography, 2018 - 2030 (USD Million)
Table 13 Company market share, 2024
Table 14 Key companies undergo other strategies.
Table 15 List of other players in Europe and MEA
List of Figures
Fig. 1 Blood collection market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Site and Application segment snapshot
Fig. 11 End use and age segment snapshot
Fig. 12 Demography segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Blood collection market value, 2023 (USD Billion)
Fig. 15 Market dynamics
Fig. 16 Number of red blood units transfused (in thousands) vs percent of supply in the U.S.
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTLE analysis
Fig. 19 U.S. blood collection market: Site outlook and key takeaways
Fig. 20 U.S. blood collection market: Site movement analysis
Fig. 21 Venous market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Venous market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 23 Needles and syringes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Needles and syringes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 25 Double-ended needles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Double-ended needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 27 Winged blood collection sets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Winged blood collection sets market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 29 Standard hypodermic needles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Standard hypodermic needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 31 Other blood collection needles market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Other blood collection needles market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 33 Blood collection tubes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Blood collection tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 35 Serum-separating tubes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Serum-separating tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 37 EDTA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 EDTA market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 39 Heparin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Heparin market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 41 Plasma-separating market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Plasma-separating market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 43 Blood bags market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Blood bags market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 47 Capillary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Capillary market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 49 Lancets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Lancets market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 51 Micro-container tubes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Micro-container tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 53 Micro-hematocrit tubes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Micro-hematocrit tubes market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 55 Warming devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Warming devices market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 57 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Others market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 59 U.S. blood collection market: Application outlook and key takeaways
Fig. 60 U.S. blood collection market: Application movement analysis
Fig. 61 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Diagnostics market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 63 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Treatment market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 65 U.S. blood collection market: End-use outlook and key takeaways
Fig. 66 U.S. blood collection market: End-use movement analysis
Fig. 67 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Hospitals market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 69 Clinical laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Clinical laboratories market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 71 Blood bank centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Blood bank centers market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 73 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Clinics market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 75 Mobile service market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Mobile service market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 77 Emergency departments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Emergency departments market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 79 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Others market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 81 U.S. blood collection market: Age outlook and key takeaways
Fig. 82 U.S. blood collection market: Age movement analysis
Fig. 83 0-18 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 0-18 market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 85 19-65 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 19-65 market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 87 66 years and above market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 66 years and above market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 89 U.S. blood collection market: Demography outlook and key takeaways
Fig. 90 U.S. blood collection market: Demography movement analysis
Fig. 91 Urban market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 92 Urban market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 93 Rural market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 94 Rural market estimates and forecast, 2018 - 2030 (Volume, Number of Blood Draws Million)
Fig. 95 U.S. blood collection market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 California blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 97 California blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 98 Previous year of percentage of adults with chances of developing cardiovascular disease in California and U.S., in 2022
Fig. 99 Texas blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 100 Texas blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 101 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Texas and U.S.
Fig. 102 Florida blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 103 Florida blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 104 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Florida and U.S.
Fig. 105 New York blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 106 New York blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 107 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in New York and U.S.
Fig. 108 Pennsylvania blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 109 Pennsylvania blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 110 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Pennsylvania and U.S.
Fig. 111 Illinois blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 112 Illinois blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 113 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Illinois and U.S.
Fig. 114 Ohio blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 115 Ohio blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 116 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Ohio and U.S.
Fig. 117 Georgia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 118 Georgia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 119 Some blood establishments prepare a small amount of whole blood specifically for direct transfusion, in U.S., in 2022
Fig. 120 Percentage of population affected by chronic disease in Georgia, in 2023
Fig. 121 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Georgia and U.S.
Fig. 122 North Carolina blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 123 North Carolina blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 124 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in North Carolina and U.S.
Fig. 125 South Carolina blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 126 South Carolina blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 127 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in South Carolina and U.S.
Fig. 128 Michigan blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 129 Michigan blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 130 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Michigan and U.S.
Fig. 131 Alabama blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 132 Alabama blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 133 Arkansas blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 134 Arkansas blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 135 Kentucky blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 136 Kentucky blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 137 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Kentucky and U.S.
Fig. 138 Louisiana blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 139 Louisiana blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 140 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Louisiana and U.S.
Fig. 141 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Louisiana and U.S.
Fig. 142 Mississippi blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 143 Mississippi blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 144 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Mississippi and U.S.
Fig. 145 Tennessee blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 146 Tennessee blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 147 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Tennessee and U.S.
Fig. 148 West Virginia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 149 West Virginia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 150 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in West Virginia and U.S.
Fig. 151 Virginia blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 152 Virginia blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 153 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Virginia and U.S.
Fig. 154 Colorado blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 155 Colorado blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 156 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Colorado and U.S.
Fig. 157 Alaska blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 158 Alaska blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 159 Vermont blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 160 Vermont blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 161 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Vermont and U.S.
Fig. 162 South Dakota blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 163 South Dakota blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 164 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in South Dakota and U.S.
Fig. 165 Maine blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 166 Maine blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 167 Incidence: top 10 cancers, Maine 2020
Fig. 168 Previous year comparison of percentage of adults with chances of developing cardiovascular disease in Maine and U.S.
Fig. 169 Oregon blood collection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 170 Oregon blood collection market estimates and forecast, 2018 - 2030 (Volume Million Units Sold)
Fig. 171 Key company categorization
